medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2025, Number 3

<< Back Next >>

Acta Ortop Mex 2025; 39 (3)

Medium and long-term survival of Synergy femoral stem in cementless total hip arthroplasty

García-Dobarganes-Barlow F, Esquivel-Solorio A, García-Saud A, Murray-López G, Garcini-Munguía F, Guevara-Álvarez A, Negrete-Corona J

Language: Spanish
References: 20
Page: 145-151
PDF size: 288.70 Kb.


ABSTRACT

Introduction: hip osteoarthritis is one of the most disabling conditions affecting the quality of life in the elderly, with a current prevalence of 10%. Advanced treatment for this condition generally involves total hip arthroplasty. Recently, there has been a shift from using cemented stems to uncemented stems due to the excellent clinical and radiological outcomes achieved with the latter. Material and methods: a retrospective review was conducted of 578 total hip arthroplasties using a tapered uncemented stem performed between 2003 and 2018. The average age of the patients was 62.92 years, with a mean follow-up of 14.03 years. Follow-up ranged from 5 to 20 years. Results: the revision rate for any reason was 2.3%, with a polyethylene wear rate of 1.0%, a deep infection rate of 0.9%, and a dislocation rate of 0.3%. No revisions were reported for aseptic loosening. The survival rate for aseptic loosening was 100%, and the overall survival rate was 97.7%. The rate of complications that did not require revision was 5.0%, while the total complication rate was 7.2%. Conclusion: the third generation tapered uncemented titanium stem shows excellent short- and medium-term results, with adequate osteointegration. It is expected to continue showing favorable long-term results, with aseptic loosening being the primary reason for revision.


REFERENCES

  1. Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010; 26(3): 355-69. doi: 10.1016/j.cger.2010.03.001.

  2. Litwic A, Edwards MH, Dennison EM, Cooper C. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013; 105: 185-99. doi: 10.1093/bmb/lds038.

  3. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019; 393(10182): 1745-59. doi: 10.1016/S0140-6736(19)30417-9.

  4. Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021; 325(6): 568-78. doi: 10.1001/jama.2020.22171.

  5. Malchau H, Herberts P, Eisler T, Garellick G, Söderman P. The swedish total hip replacement register. J Bone Joint Surg Am. 2002; 84-A Suppl 2: 2-20. doi: 10.2106/00004623-200200002-00002.

  6. Wall PD, Brown JS, Parsons N, Buchbinder R, Costa ML, Griffin D. Surgery for treating hip impingement (femoroacetabular impingement). Cochrane Database Syst Rev. 2014; 2014(9): CD010796.

  7. Panichkul P, McCalden RW, MacDonald SJ, Somerville LE, Naudie DN. Minimum 15-year results of a dual-offset uncemented femoral stem in total hip arthroplasty. J Arthroplasty. 2019; 34(12): 2992-8.

  8. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007; 89(4): 780-5.

  9. Tyrpenou E, Khoshbin A, Mohammad S, Schemitsch EH, Waddell JP, Atrey A. A large-scale fifteen-year minimum survivorship of a cementless triple tapered femoral stem. J Arthroplasty. 2020; 35(8): 2161-6.

  10. Danesh-Clough T, Bourne RB, Rorabeck CH, McCalden R. The mid-term results of a dual offset uncemented stem for total hip arthroplasty. J Arthroplasty. 2007; 22(2): 195-203.

  11. Engh CA, Bobyn JD, Glassman AH. Porous-coated hip replacement. The factors governing bone ingrowth, stress shielding, and clinical results. J Bone Joint Surg Br. 1987; 69(1): 45-55.

  12. Engh CA, Massin P, Suthers KE. Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components. Clin Orthop Relat Res. 1990; (257): 107-28.

  13. Petis SM, Howard JL, McAuley JP, Somerville L, McCalden RW, MacDonald SJ. Comparing the long-term results of two uncemented femoral stems for total hip arthroplasty. J Arthroplasty. 2015; 30(5): 781-5.

  14. MacDonald SJ, Rosenzweig S, Guerin JS, McCalden RW, Bohm ER, Bourne RB, et al. Proximally versus fully porous-coated femoral stems: a multicenter randomized trial. Clin Orthop Relat Res. 2010; 468(2): 424-32.

  15. Nikolaou VS, Edwards MR, Bogoch E, Schemitsch EH, Waddell JP. A prospective randomised controlled trial comparing three alternative bearing surfaces in primary total hip replacement. J Bone Joint Surg Br. 2012; 94(4): 459-65.

  16. Nishino T, Mishima H, Kawamura H, Shimizu Y, Miyakawa S, Ochiai N. Follow-up results of 10-12 years after total hip arthroplasty using cementless tapered stem -- frequency of severe stress shielding with synergy stem in Japanese patients. J Arthroplasty. 2013; 28(10): 1736-40.

  17. De Martino I, De Santis V, D'Apolito R, Sculco PK, Cross MB, Gasparini G. The Synergy cementless femoral stem in primary total hip arthroplasty at a minimum follow-up of 15 years. Bone Joint J. 2017; 99-B(1): 29-36.

  18. Müller LA, Wenger N, Schramm M, Hohmann D, Forst R, Carl HD. Seventeen-year survival of the cementless CLS Spotorno stem. Arch Orthop Trauma Surg. 2010; 130(2): 269-75.

  19. Vidalain JP. Twenty-year results of the cementless Corail stem. Int Orthop. 2011; 35(2): 189-94.

  20. Capello WN, D'Antonio JA, Jaffe WL, Geesink RG, Manley MT, Feinberg JR. Hydroxyapatite-coated femoral components: 15-year minimum followup. Clin Orthop Relat Res. 2006; 453: 75-80.



EVIDENCE LEVEL

II




2020     |     www.medigraphic.com